| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.7 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.08 | 0.7 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.088 | 0.7 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.068 | 0.7 |